Clinical trial
Zolpidem Postmarketing Study in Adolescent Patients With Insomnia
NCT00432198 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00432198 |
|---|---|
| Title | Zolpidem Postmarketing Study in Adolescent Patients With Insomnia |
| Official title | Zolpidem Postmarketing Clinical Study: A Double Blind, Placebo Controlled Group Comparative Trial in the Adolescent Patients With Insomnia |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | Zolpidem (Myslee®), placebo |
| Enrollment | 122 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Feb 7, 2007 |
| Last update posted | Feb 17, 2017 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: